Jim Cramer - Mad Money Sorrento Therapeutics SRNE-Q DON'T BUY Jun 30, 2021

Not a meme stock but it has too much hot money in it.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$9.690

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

RISKY

A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jim Cramer - Mad Money Sorrento Therapeutics SRNE-Q DON'T BUY Jun 30, 2021

You might be interested:

Sorrento Therapeutics(SRNE-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Kim Bolton

Stockchase Insights

Jim Cramer - Mad Money

Paul Harris, CFA

The Panic-Proof Portfolio (Stockchase Research)